Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets open in 3 hours 4 minutes

S&P Futures
5,756.00
+12.75(+0.22%)
Dow Futures
42,024.00
+68.00(+0.16%)
Nasdaq Futures
20,156.00
+70.00(+0.35%)
Russell 2000 Futures
2,232.90
+1.80(+0.08%)
Crude Oil
71.82
+0.35(+0.49%)
Gold
2,748.10
+1.90(+0.07%)

Quantum BioPharma Ltd. (QNTM)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD

Follow

4.6200

-0.2200

(-4.55%)

At close: 04:00PM EST

4.4000

-0.22

(-4.76%)

After hours:

04:31PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	8.74M
Enterprise Value	6.03M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	91.86
Price/Book (mrq)	0.78
Enterprise Value/Revenue	98.56
Enterprise Value/EBITDA	-1.57

Trading Information

Stock Price History

Beta (5Y Monthly)	0.83
52-Week Change ³	-92.78%
S&P500 52-Week Change ³	30.84%
52 Week High ³	97.5000
52 Week Low ³	3.5000
50-Day Moving Average ³	4.5704
200-Day Moving Average ³	23.4103

Share Statistics

Avg Vol (3 month) ³	520.52k
Avg Vol (10 day) ³	163.16k
Shares Outstanding ⁵	1.86M
Implied Shares Outstanding ⁶	1.9M
Float ⁸	1.07M
% Held by Insiders ¹	13.73%
% Held by Institutions ¹	1.50%
Shares Short (Oct 15, 2024) ⁴	10.09k
Short Ratio (Oct 15, 2024) ⁴	0.2
Short % of Float (Oct 15, 2024) ⁴	0.57%
Short % of Shares Outstanding (Oct 15, 2024) ⁴	0.54%
Shares Short (prior month Sep 13, 2024) ⁴	116.37k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:65
Last Split Date ³	Aug 15, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	-36.12%
Return on Equity (ttm)	-63.89%

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	N/A
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	-10.06M
Net Income Avi to Common (ttm)	-7.47M
Diluted EPS (ttm)	-13.0000
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	3.33M
Total Cash Per Share (mrq)	2.56
Total Debt (mrq)	625.2k
Total Debt/Equity (mrq)	6.13%
Current Ratio (mrq)	1.99
Book Value Per Share (mrq)	15.02

Cash Flow Statement

Operating Cash Flow (ttm)	-5.14M
Levered Free Cash Flow (ttm)	-9.99M